×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • BAKER BROS. ADVISORS LP (Data extracted from 13F, 13D, 13G and Form 4)

BAKER BROS. ADVISORS LP

AUM: $21.98 B
13-F Portfolio Value: $19.96 B
Last 13-F Filed: Q2 2026
Concentration in top 10: 72.83%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
SMMTSummit Therapeutics Inc.0.83%32,786,348$477,697,090-3,604,715-9.91%$14.5713F
CELCCelcuity Inc.0.78%4,372,852$448,217,330-3,542,940-44.76%Form 4
IMVTImmunovant, Inc.0.36%5,435,220$209,419,027-22,661-0.42%$38.5313F
ROIVRoivant Sciences Ltd.0.29%4,716,831$166,928,649-150,892-3.1%$35.3913F
EWTXEdgewise Therapeutics, Inc.0.26%3,701,719$150,400,843-2,874,221-43.71%$40.6313F
IMTXImmatics N.V.0.17%9,508,565$96,321,763-1,408,128-12.9%$10.1313F
JBIOJade Biosciences, Inc.0.05%1,230,426$27,340,066-410,711-25.03%$22.2213F
CERSCerus Corporation0.03%6,395,431$18,674,659-3,612,914-36.1%$2.9213F